The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| SRTS | -48.82% | +28.09% | +5.08% | -43% |
| S&P | +18.37% | +110.18% | +16.02% | +217% |
Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $7.32M | -20.8% |
| Gross Profit | $2.90M | -46.5% |
| Gross Margin | 39.69% | -19.0% |
| Market Cap | $77.95M | -10.8% |
| Market Cap / Employee | $1.44M | 0.0% |
| Employees | 54 | 54.3% |
| Net Income | -$1.04M | -164.3% |
| EBITDA | -$1.79M | -186.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $22.16M | 16.8% |
| Accounts Receivable | $12.62M | -31.0% |
| Inventory | 15.1 | -6.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.34M | -31.8% |
| Short Term Debt | $0.25M | 29.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -1.45% | -13.5% |
| Return On Invested Capital | 9.59% | 3.5% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $3.09M | -26.9% |
| Operating Free Cash Flow | $3.12M | -26.3% |
| Metric | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 13.07 | 10.15 | 17.02 | 43.04 | 223.36% |
| Price to Book | 1.80 | 2.10 | 1.40 | 1.47 | -13.86% |
| Price to Sales | 2.30 | 2.72 | 1.96 | 2.06 | -13.98% |
| Price to Tangible Book Value | 1.80 | 2.10 | 1.40 | 1.47 | -13.86% |
| Price to Free Cash Flow TTM | 45.34 | 16.70 | 22.15 | - | |
| Enterprise Value to EBITDA | 45.65 | 49.63 | -23.54 | -31.25 | -193.65% |
| Free Cash Flow Yield | 2.2% | 6.0% | 4.5% | - | |
| Return on Equity | 18.9% | 12.7% | 3.5% | -1.6% | -112.03% |
| Total Debt | $0.65M | $0.60M | $0.65M | $0.60M | -14.76% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
